《强生Johnson&Johnson（JNJ）2025第四季度及全年其他财务信息披露「NYSE」（英文版）（17页）.pdf》由会员分享，可在线阅读，更多相关《强生Johnson&Johnson（JNJ）2025第四季度及全年其他财务信息披露「NYSE」（英文版）（17页）.pdf（17页珍藏版）》请在三个皮匠报告上搜索。

1、Table 1:Sales by Segment 1Table 2:Sales by Geographic Area2Table 3:Sales of Key Products/Franchises3-7Table 4:Condensed Consolidated Statement of Earnings-QTD8Table 5:Condensed Consolidated Statement of Earnings-YTD9Table 6:Non-GAAP Adjusted Operational Sales Growth-QTD10Table 7:Non-GAAP Adjusted Op

2、erational Sales Growth-YTD11Table 8:Non-GAAP Adjusted Net Earnings12Table 9:Non-GAAP P&L by Segment Reconciliation 2025-QTD13Table 10:Non-GAAP P&L by Segment Reconciliation 2024-QTD14Table 11:Non-GAAP P&L by Segment Reconciliation 2025-YTD15Table 12:Non-GAAP P&L by Segment Reconciliation 2024-YTD16F

3、ourth Quarter 2025Other Financial DisclosuresTable of ContentsJohnson&Johnson and SubsidiariesSupplementary Sales Data(Unaudited;Dollars in Millions)Percent Change20252024TotalOperationsCurrency20252024TotalOperationsCurrencySales to customers bysegment of businessInnovative Medicine U.S.9,689$8,977

4、 7.9%7.9 -36,344$33,970 7.0%7.0 -International6,074 5,355 13.4 7.9 5.5 24,057 22,994 4.6 2.9 1.7 15,763 14,332 10.0 7.9 2.1 60,401 56,964 6.0 5.3 0.7 MedTech U.S.4,506 4,227 6.6 6.6 -17,408 16,332 6.6 6.6 -International4,295 3,961 8.5 4.9 3.6 16,384 15,525 5.5 4.1 1.4 8,801 8,188 7.5 5.8 1.7 33,792

5、31,857 6.1 5.4 0.7 U.S.14,195 13,204 7.5 7.5 -53,752 50,302 6.9 6.9 -International10,369 9,316 11.3 6.6 4.7 40,441 38,519 5.0 3.4 1.6 Worldwide24,564$22,520 9.1%7.1 2.0 94,193$88,821 6.0%5.3 0.7 Note:Percentages have been calculated using actual,non-rounded figures and,therefore,may not recalculate

6、precisely.FOURTH QUARTERTWELVE MONTHS Percent ChangeJohnson&Johnson and SubsidiariesSupplementary Sales Data(Unaudited;Dollars in Millions)Percent Change20252024TotalOperationsCurrency20252024TotalOperationsCurrencySales to customers bygeographic areaU.S.14,195$13,204 7.5%7.5 -53,752$50,302 6.9%6.9